Food Allergy Therapy: Is a Cure Within Reach?

Pediatric Clinics of North America

Volumn 58, Issue 2, 2011, Pages 511-530

  Nowak Wegrzyn, Anna ^a   Muraro, Antonella ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Egg allergy; Food allergy; Food allergy therapy; Immunotherapy; Milk allergy; Oral desensitization; Oral immunotherapy; Peanut allergy

Indexed keywords

CHINESE DRUG; EGG PROTEIN; FOOD ALLERGEN; HAZELNUT EXTRACT; IMMUNOGLOBULIN E ANTIBODY; INTERLEUKIN 10; MILK PROTEIN; PEANUT PROTEIN; PLACEBO; PLANT EXTRACT; POLLEN ANTIGEN; PREBIOTIC AGENT; PROBIOTIC AGENT; PROTEIN; TALIZUMAB; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ALLERGIC RHINITIS; ASTHMA; ATOPIC DERMATITIS; BIRCH; CHINESE MEDICINE; DESENSITIZATION; DIARRHEA; DOSE RESPONSE; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG WITHDRAWAL; ECZEMA; EGG ALLERGY; FOOD ALLERGY; GASTROINTESTINAL SYMPTOM; HAZELNUT; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOTHERAPY; LARYNX DISORDER; MILK ALLERGY; NAUSEA; NONHUMAN; NUTRITIONAL TOLERANCE; ORAL PRURITUS; PATCH TEST; PEANUT ALLERGY; POLLEN ALLERGY; PRICK TEST; PROTEIN EXPRESSION; PROTEIN INTAKE; PRURITUS; RESPIRATORY TRACT DISEASE; REVIEW; SIDE EFFECT; SKIN DISEASE; SNEEZING; VOMITING;

ALLERGENS; ANAPHYLAXIS; ANTIBODIES, ANTI-IDIOTYPIC; CHILD; CLINICAL TRIALS AS TOPIC; COOKING; DESENSITIZATION, IMMUNOLOGIC; FOOD HYPERSENSITIVITY; HUMANS; IMMUNE TOLERANCE; IMMUNOTHERAPY; MEDICINE, CHINESE TRADITIONAL; PROBIOTICS;

EID: 79953101357     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcl.2011.02.010     Document Type: Review

References (72)

1. Sicherer S.H., Sampson H.A. Food allergy: recent advances in pathophysiology and treatment. Annu Rev Med 2009, 60:261-277.
2. Branum A.M., Lukacs S.L. Food allergy among children in the United States. Pediatrics 2009, 124(6):1549-1555.
3. Skripak J.M., Sampson H.A. Towards a cure for food allergy. Curr Opin Immunol 2008, 20(6):690-696.
4. Scurlock A.M., Burks A.W., Jones S.M. Oral immunotherapy for food allergy. Curr Allergy Asthma Rep 2009, 9(3):186-193.
5. Shreffler W.G., Beyer K., Chu T.H., et al. Microarray immunoassay: association of clinical history, in vitro IgE function, and heterogeneity of allergenic peanut epitopes. J Allergy Clin Immunol 2004, 113(4):776-782.
6. Flinterman A.E., Knol E.F., Lencer D.A., et al. Peanut epitopes for IgE and IgG4 in peanut-sensitized children in relation to severity of peanut allergy. J Allergy Clin Immunol 2008, 121(3):737-743.
7. Wang J., Lin J., Bardina L., et al. Correlation of IgE/IgG4 milk epitopes and affinity of milk-specific IgE antibodies with different phenotypes of clinical milk allergy. J Allergy Clin Immunol 2010, 125(3):695-702.
8. Cooke S.K., Sampson H.A. Allergenic properties of ovomucoid in man. J Immunol 1997, 159(4):2026-2032.
9. Chatchatee P., Jarvinen K.M., Bardina L., et al. Identification of IgE- and IgG-binding epitopes on alpha(s1)-casein: differences in patients with persistent and transient cow's milk allergy. J Allergy Clin Immunol 2001, 107(2):379-383.
10. Savage J.H., Matsui E.C., Skripak J.M., et al. The natural history of egg allergy. J Allergy Clin Immunol 2007, 120(6):1413-1417.
11. Skripak J.M., Matsui E.C., Mudd K., et al. The natural history of IgE-mediated cow's milk allergy. J Allergy Clin Immunol 2007, 120(5):1172-1177.
12. MacGlashan D.W.J., Bochner B.S., Adelman D.C., et al. Down-regulation of Fc(epsilon)RI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody. J Immunol 1997, 158:1438-1445.
13. Leung D.Y., Sampson H.A., Yunginger J.W., et al. Effect of anti-IgE therapy in patients with peanut allergy. N Engl J Med 2003, 348(11):986-993.
14. Kuehr J., Brauburger J., Zielen S., et al. Efficacy of combination treatment with anti-IgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitis. J Allergy Clin Immunol 2002, 109(2):274-280.
15. Li X.M., Zhang T.F., Huang C.K., et al. Food allergy herbal formula -1 (FAHF-1) blocks peanut-induced anaphylaxis in a murine model. J Allergy Clin Immunol 2001, 108:639-646.
16. Srivastava K.D., Kattan J.D., Zou Z.M., et al. The Chinese herbal medicine formula FAHF-2 completely blocks anaphylactic reactions in a murine model of peanut allergy. J Allergy Clin Immunol 2005, 115(1):171-178.
17. Wang J., Patil S.P., Yang N., et al. Safety, tolerability, and immunologic effects of a food allergy herbal formula in food allergic individuals: a randomized, double-blinded, placebo-controlled, dose escalation, phase 1 study. Ann Allergy Asthma Immunol 2010, 105(1):75-84.
18. Qu C., Srivastava K., Ko J., et al. Induction of tolerance after establishment of peanut allergy by the food allergy herbal formula-2 is associated with up-regulation of interferon-gamma. Clin Exp Allergy 2007, 37(6):846-855.
19. Srivastava K.D., Qu C., Zhang T., et al. Food Allergy Herbal Formula-2 silences peanut-induced anaphylaxis for a prolonged posttreatment period via IFN-gamma-producing CD8+ T cells. J Allergy Clin Immunol 2009, 123(2):443-451.
20. Oppenheimer J.J., Nelson H.S., Bock S.A., et al. Treatment of peanut allergy with rush immunotherapy. J Allergy Clin Immunol 1992, 90(2):256-262.
21. Nelson H.S., Lahr J., Rule R., et al. Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract. J Allergy Clin Immunol 1997, 99(6 Pt 1):744-751.
22. Asero R. Effects of birch pollen-specific immunotherapy on apple allergy in birch pollen-hypersensitive patients. Clin Exp Allergy 1998, 28:1368-1373.
23. Asero R. How long does the effect of birch pollen injection SIT on apple allergy last?. Allergy 2003, 58(5):435-438.
24. Bucher X., Pichler W.J., Dahinden C.A., et al. Effect of tree pollen specific, subcutaneous immunotherapy on the oral allergy syndrome to apple and hazelnut. Allergy 2004, 59(12):1272-1276.
25. Bolhaar S.T., Tiemessen M.M., Zuidmeer L., et al. Efficacy of birch-pollen immunotherapy on cross-reactive food allergy confirmed by skin tests and double-blind food challenges. Clin Exp Allergy 2004, 34(5):761-769.
26. Alonso R., Enrique E., Pineda F., et al. An observational study on outgrowing food allergy during non-birch pollen-specific, subcutaneous immunotherapy. Int Arch Allergy Immunol 2007, 143(3):185-189.
27. Kinaciyan T., Jahn-Schmid B., Radakovics A., et al. Successful sublingual immunotherapy with birch pollen has limited effects on concomitant food allergy to apple and the immune response to the Bet v 1 homolog Mal d 1. J Allergy Clin Immunol 2007, 119(4):937-943.
28. Schofield A.T. A case of egg poisoning. Lancet 1908, 1:716.
29. Chehade M., Mayer L. Oral tolerance and its relation to food hypersensitivities. J Allergy Clin Immunol 2005, 115(1):3-12.
30. Strid J., Hourihane J., Kimber I., et al. Epicutaneous exposure to peanut protein prevents oral tolerance and enhances allergic sensitization. Clin Exp Allergy 2005, 35(6):757-766.
31. Patriarca C., Romano A., Venuti A., et al. Oral specific hyposensitization in the management of patients allergic to food. Allergol Immunopathol (Madr) 1984, 12(4):275-281.
32. Patriarca G., Schiavino D., Nucera E., et al. Food allergy in children: results of a standardized protocol for oral desensitization. Hepatogastroenterology 1998, 45(19):52-58.
33. Patriarca G., Nucera E., Roncallo C., et al. Oral desensitizing treatment in food allergy: clinical and immunological results. Aliment Pharmacol Ther 2003, 17(3):459-465.
34. Patriarca G., Nucera E., Pollastrini E., et al. Oral rush desensitization in peanut allergy: a case report. Dig Dis Sci 2006, 51(3):471-473.
35. Rolinck-Werninghaus C., Staden U., Mehl A., et al. Specific oral tolerance induction with food in children: transient or persistent effect on food allergy?. Allergy 2005, 60(10):1320-1322.
36. Staden U., Rolinck-Werninghaus C., Brewe F., et al. Specific oral tolerance induction in food allergy in children: efficacy and clinical patterns of reaction. Allergy 2007, 62(11):1261-1269.
37. Skripak J.M., Nash S.D., Rowley H., et al. A randomized, double-blind, placebo-controlled study of milk oral immunotherapy for cow's milk allergy. J Allergy Clin Immunol 2008, 122(6):1154-1160.
38. Longo G., Barbi E., Berti I., et al. Specific oral tolerance induction in children with very severe cow's milk-induced reactions. J Allergy Clin Immunol 2008, 121(2):343-347.
39. Buchanan A.D., Green T.D., Jones S.M., et al. Egg oral immunotherapy in nonanaphylactic children with egg allergy. J Allergy Clin Immunol 2007, 119(1):199-205.
40. Jones S.M., Pons L., Roberts J.L., et al. Clinical efficacy and immune regulation with peanut oral immunotherapy. J Allergy Clin Immunol 2009, 124(2):292-300.
41. Clark A.T., Islam S., King Y., et al. Successful oral tolerance induction in severe peanut allergy. Allergy 2009, 64(8):1218-1220.
42. Hofmann A.M., Scurlock A.M., Jones S.M., et al. Safety of a peanut oral immunotherapy protocol in children with peanut allergy. J Allergy Clin Immunol 2009, 124(2):286-291.
43. Narisety S.D., Skripak J.M., Steele P., et al. Open-label maintenance after milk oral immunotherapy for IgE-mediated cow's milk allergy. J Allergy Clin Immunol 2009, 124(3):610-612.
44. Varshney P., Steele P.H., Vickery B.P., et al. Adverse reactions during peanut oral immunotherapy home dosing. J Allergy Clin Immunol 2009, 124(6):1351-1352.
45. Mempel M., Rakoski J., Ring J., et al. Severe anaphylaxis to kiwi fruit: immunologic changes related to successful sublingual allergen immunotherapy. J Allergy Clin Immunol 2003, 111(6):1406-1409.
46. Kerzl R., Simonowa A., Ring J., et al. Life-threatening anaphylaxis to kiwi fruit: protective sublingual allergen immunotherapy effect persists even after discontinuation. J Allergy Clin Immunol 2007, 119(2):507-508.
47. Enrique E., Pineda F., Malek T., et al. Sublingual immunotherapy for hazelnut food allergy: a randomized, double-blind, placebo-controlled study with a standardized hazelnut extract. J Allergy Clin Immunol 2005, 116(5):1073-1079.
48. De Boissieu D., Dupont C. Sublingual immunotherapy for cow's milk protein allergy: a preliminary report. Allergy 2006, 61(10):1238-1239.
49. Senti G., Graf N., Haug S., et al. Epicutaneous allergen administration as a novel method of allergen-specific immunotherapy. J Allergy Clin Immunol 2009, 124(5):997-1002.
50. Mondoulet L., Dioszeghy V., Ligouis M., et al. Epicutaneous immunotherapy on intact skin using a new delivery system in a murine model of allergy. Clin Exp Allergy 2010, 40(4):659-667.
51. Dupont C., Kalach N., Soulaines P., et al. Cow's milk epicutaneous immunotherapy in children: a pilot trial of safety, acceptability, and impact on allergic reactivity. J Allergy Clin Immunol 2010, 125(5):1165-1167.
52. Nowak-Wegrzyn A., Bloom K.A., Sicherer S.H., et al. Tolerance to extensively heated milk in children with cow's milk allergy. J Allergy Clin Immunol 2008, 122(2):342-347. 347.
53. Lemon-Mule H., Sampson H.A., Sicherer S.H., et al. Immunologic changes in children with egg allergy ingesting extensively heated egg. J Allergy Clin Immunol 2008, 122(5):977-983.
54. Wanich N., Nowak-Wegrzyn A., Sampson H.A., et al. Allergen-specific basophil suppression associated with clinical tolerance in patients with milk allergy. J Allergy Clin Immunol 2009, 123(4):789-794.
55. Shreffler W.G., Wanich N., Moloney M., et al. Association of allergen-specific regulatory T cells with the onset of clinical tolerance to milk protein. J Allergy Clin Immunol 2009, 123(1):43-52.
56. Bannon G.A., Cockrell G., Connaughton C., et al. Engineering, characterization and in vitro efficacy of the major peanut allergens for use in immunotherapy. Int Arch Allergy Immunol 2001, 124(1-3):70-72.
57. Srivastava K.D., Li X.M., King N., et al. Immunotherapy with modified peanut allergens in a murine model of peanut allergy. J Allergy Clin Immunol 2002, 109:S287. [abstract].
58. Li X.M., Srivastava K., Huleatt J.W., et al. Engineered recombinant peanut protein and heat-killed Listeria monocytogenes coadministration protects against peanut-induced anaphylaxis in a murine model. J Immunol 2003, 170(6):3289-3295.
59. Li X.M., Srivastava K., Grishin A., et al. Persistent protective effect of heat-killed Escherichia coli producing "engineered," recombinant peanut proteins in a murine model of peanut allergy. J Allergy Clin Immunol 2003, 112(1):159-167.
60. Kalliomaki M., Salminen S., Arvilommi H. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001, 357:1076-1079.
61. Gruber C., van S.M., Mosca F., et al. Reduced occurrence of early atopic dermatitis because of immunoactive prebiotics among low-atopy-risk infants. J Allergy Clin Immunol 2010, 126(4):791-797.
62. Kalliomaki M., Salminen S., Poussa T., et al. Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial. J Allergy Clin Immunol 2007, 119(4):1019-1021.
63. Majamaa H., Isolauri E. Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol 1997, 99:179-185.
64. Isolauri E., Juntunen M., Sillanaukee P., et al. A human Lactobacillus strain (Lactobacillus GG) promotes recovery from acute diarrhea in children. Pediatrics 1989, 88:90-97.
65. Pessi T., Sutas Y., Hurme M., et al. Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG. Clin Exp Allergy 2000, 30:1804-1808.
66. Sutas Y., Hurme M., Isolauri E. Downregulation of antiCD3 antibody-induced IL-4 production by bovine caseins hydrolysed with Lactobacillus GG-derived enzymes. Scand J Immunol 1996, 43:687-689.
67. Frossard C.P., Steidler L., Eigenmann P.A. Oral administration of an IL-10-secreting Lactococcus lactis strain prevents food-induced IgE sensitization. J Allergy Clin Immunol 2007, 119(4):952-959.
68. Li S., Li X.M., Burks A.W., et al. Modulation of peanut allergy by peptide-based immunotherapy. J Allergy Clin Immunol 2001, 107:S233. [abstract].
69. Horner A.A., Nguyen M.D., Ronaghy A., et al. DNA-based vaccination reduces the risk of lethal anaphylactic hypersensitivity in mice. J Allergy Clin Immunol 2000, 106(2):349-356.
70. Roy K., Mao H.Q., Huang S.K., et al. Oral gene delivery with chitosan-DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat Med 1999, 5(4):387-391.
71. Nguyen M.D., Cinman N., Yen J., et al. DNA-based vaccination for the treatment of food allergy. Allergy 2001, 56(Suppl 67):127-130.
72. Srivastava K., Li X.M., Bannon G.A., et al. Investigation of the use of ISS-linked Ara h2 for the treatment of peanut-induced allergy. J Allergy Clin Immunol 2001, 107:S233. [abstract].